SCHEMBL23313220

SCHEMBL23313220

Cc1ccc2ccc(OC[C@H]3O[C@@H](n4cc(C)c5c(C)ncnc54)[C@H](O)[C@@H]3O)cc2n1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 14/20 0.73
▸ METTL3 Q86U44 13/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313214 0.91 METTL3 (0.72) PRMT5METTL3
SCHEMBL25015913 0.84 PRMT5 (1.00) PRMT5METTL3
SCHEMBL25015669 0.83 PRMT5 (1.00) PRMT5METTL3
SCHEMBL18572075 0.81 PRMT5 (0.81) PRMT5METTL3
SCHEMBL22002187 0.80 METTL3 (0.84) PRMT5METTL3
SCHEMBL25015663 0.78 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23313083 0.77 PRMT5 (1.00) PRMT5METTL3
SCHEMBL25016895 0.76 METTL3 (1.00) PRMT5METTL3
SCHEMBL17816346 0.76 ADK (0.61) —
SCHEMBL17816351 0.76 ADK (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback